期刊文献+

Synthesis and in vitro Antibacterial Activities of 5-(2,3,4,5- Tetrahydro-1 H-chromeno[2,3-dJpyrimidin-5-yl)pyrimidione Derivatives

Synthesis and in vitro Antibacterial Activities of 5-(2,3,4,5- Tetrahydro-1 H-chromeno[2,3-dJpyrimidin-5-yl)pyrimidione Derivatives
原文传递
导出
摘要 A series of novel 5-(2,3,4,5-tetrahydro-lH-chromeno[2,3-d]pyrimidin-5-yl)pyrimidione derivatives have been synthesized from substituted salicylaldehydes and barbituric acid or 2-thiobarbituric acid in water catalyzed by phase transfer catalysis of triethylbenzyl ammonium chloride (TEBA). Elemental analysis, IR, 1HNMR, and 13C NMR elucidated the structures of all the newly synthesized compounds. In vitro antimicrobial activities of synthesized compounds have been investigated against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudornonas aeruginosa. These newly synthesized derivatives exhibited significant in vitro antibacterial activity. A series of novel 5-(2,3,4,5-tetrahydro-lH-chromeno[2,3-d]pyrimidin-5-yl)pyrimidione derivatives have been synthesized from substituted salicylaldehydes and barbituric acid or 2-thiobarbituric acid in water catalyzed by phase transfer catalysis of triethylbenzyl ammonium chloride (TEBA). Elemental analysis, IR, 1HNMR, and 13C NMR elucidated the structures of all the newly synthesized compounds. In vitro antimicrobial activities of synthesized compounds have been investigated against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudornonas aeruginosa. These newly synthesized derivatives exhibited significant in vitro antibacterial activity.
出处 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2012年第2期386-390,共5页 中国化学(英文版)
关键词 5-(2 3 4 5-tetrahydro-lH-chromeno[2 3-d]pyrimidin-5-yl)pyrimidione antibacterial activity phase transfer catalysis water 5-(2,3,4,5-tetrahydro-lH-chromeno[2,3-d]pyrimidin-5-yl)pyrimidione, antibacterial activity, phase transfer catalysis, water
  • 相关文献

参考文献20

  • 1Hajela, K.; Kapil, R. S. Eur. J. Med. Chem. 1997, 32, 135.
  • 2Chen, M. J.; Lee, Y. M.; Sheu, J. R.; Hu, C. T.; Yen, M. H. J. Pharm. Pharmacol. 1998, 50, 83.
  • 3Marmhold, R.; Cruciani, G.; Weber, H.; Lemoine, H.; Derix, A.; Weichel, C.; Clementi, M. J. Med. Chem. 1999, 42, 981.
  • 4Kitamura, R. O. S.; Romoff, P.; Young, M. C. M.; Kato, M. J.; Lago, J. H. G. Phytochemistry 2006, 67, 2398.
  • 5Rai, U. S.; Isloor, A. M.; Shetty, P.; Vijesh, A. M.; Prabhu, N.; isloor, S.; Thiageeswaran, M.; Fun, H. K. Eur. J. Med. Chem. 2010, 45, 2695.
  • 6Sabry, N. M.; Mohamed, H. M.; Khattab, E. S. A. E. H.; Motlaq, S S.; E1-Agrody, A. M. Eur. J. Med. Chem. 2011, 46, 765.
  • 7Tangmouo, J. G.; Meli, A. L.; Komguem, J.; Kuete, V.; Ngounou, F N.; Lontsi, D.; Beng, V. P.; Choudhary, M. I.; Sondengam, B. L Tetrahedron Lett. 2006, 47, 3067.
  • 8Abdelrazek, F. M.; Metz, P.; Kataeva, O.; Jager, A.; EI-Mahrouky, S. F. Arch. Pharm. 2007, 340, 543.
  • 9Kappe, C. O.; Fabian, W. M. F.; Semones, M. A. Tetrahedron 1997, 53, 2803.
  • 10Atwal, K. S.; Rovnyak, G. C.; O'Reilly, B. C.; Schwartz, J. J. Org. Chem. 1989, 54, 5898.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部